Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation? Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible? Year: 2006
Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway Source: Eur Respir J 2011; 37: 1237-1247 Year: 2011
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 177s Year: 2004
Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004
Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005
Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004
The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007
Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans Source: International Congress 2016 – Orphan diseases I Year: 2016
Postinfection bronchiolitis obliterans in structure of chronic lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008
Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure? Source: Eur Respir J 2011; 37: 10-12 Year: 2011
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004
Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011
Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011
Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011